Chemours Stock News

Chemours Company (The) found using ticker (CC) now have 11 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 53 and 34 with the average target price sitting at 41.18. Given that the stocks previous close was at 28.69 this would imply there is a potential upside of 43.5%. The 50 day MA is 32.94 and the 200 moving average now moves to 32.61. The market capitalisation for the company is $4,416m. Company Website: https://www.chemours.com [stock_market_widget type="chart" template="basic" color="green" assets=CC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $6,339m based on the market concensus. The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

David Einhorn's GLRE 13F stock portfolio value increased from $1.49B to $1.75B this quarter. The largest 3 positions are at ~48% of the portfolio.

A U.S. judge on Thursday ruled that Chemours Co must face shareholders'' claim that it understated the maximum costs associated with cleaning up certain long-lived chemicals after the company was spun off from E.I. du Pont de Nemours and Co.

CC earnings call for the period ending December 31, 2021.

Chemours Company (CC) shares closed today 15.4% lower than it did at the end of yesterday. The stock is currently up 5.7% year-to-date, up 36.6% over the past 12 months, and up 49.1% over the past five years. Today, the Dow Jones Industrial Average fell 1.5%, and the S&P 500 fell 2.0%. Trading Activity Shares traded as high as $36.97 and as low as $32.57 this week.Shares closed 21.7% below its 52-week high and 31.7% above its 52-week low.Trading volume this week was 31.7% higher than the 10-day average and 35.8% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Materials industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -126.0% The company's stock price performance over the past 12 months lags the peer average by -78.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Shares of Chemours (NYSE: CC) were down over 6% in the extended trading hours on February 10, after the American chemical company reported … The post Chemours Posts Mixed Q4 Results, Shares Plunge 6% appeared first on Smarter Analyst .

Gainers: LSB Industries (LXU) +13%. Gran Tierra Energy (GTE) +12%

Shares of the specialty chemicals company didn''t react well to its earnings update, though the numbers weren''t exactly terrible.

Chemours <> plunges to a two-month low after missing Q4 adjusted earnings estimates and issuing disappointing guidance for FY 2022 earnings.Q4 net income surged to $233M from $19M

The Chemours Company (CC) CEO Mark Newman Q4 2021 Results - Earnings Call Transcript

Shares of the specialty chemicals company didn't react well to its earnings update, though the numbers weren't exactly terrible.

Volumes and prices contributed favorably to Chemours' (CC) top-line growth in the fourth quarter. It sees adjusted earnings per share in the band of $4.07-$4.70 for 2022.

Chemours press release (CC): Q4 Non-GAAP EPS of $0.81 misses by $0.07.Revenue of $1.6B (+19.4% Y/Y) beats by $30M.For FY2022, the company expects Adjusted EBITDA between $1.3B…